供应链风险管理评估与战略:医院药房案例研究

Mushonnifun Faiz Sugihartanto, Muhammad Rizaldy Mahendra, Imam Baihaqi, Hanifa Rizaldy
{"title":"供应链风险管理评估与战略:医院药房案例研究","authors":"Mushonnifun Faiz Sugihartanto, Muhammad Rizaldy Mahendra, Imam Baihaqi, Hanifa Rizaldy","doi":"10.52330/jtm.v22i1.230","DOIUrl":null,"url":null,"abstract":"Health service providers such as hospitals have a very diverse supply chain in quantity and type, one of which is medicine. Hospital Pharmacy Installation (IFRS) is one of the health support activity units responsible for planning, procurement, management, storage, distribution, use of drugs, equipment, and pharmaceutical services for medical devices related to the distribution of drugs used in hospitals. Pharmacy has several risks that need to be addressed to increase customer satisfaction. This study aims to determine the extent of the implementation of Supply Chain Risk Management, identify risks in supply chain activities, and obtain risk management strategies. In this study, the method used is the assessment of Supply Chain Risk Management and continued the evaluation of the drug chain in pharmaceutical installations with the House of Risk. It is divided into two stages, namely House of Risk Stage 1, which is used to decide the risk in each supply chain, and House of Risk Stage 2, to offers a decision-making strategy for each chosen decision. There are 20 risk events and 20 risk agents in the House of Risk stage 1, and 11 proposed risk management strategies in the House of Risk stage 2. Out of 20 risks identified in stage 1, 11 risks contributed to 80% highest risk, and the top three are drug shortage, inappropriate planning, and unclear doctor’s writing. In stage 2, the three most prioritized strategies are e-prescription implementation, clear signs for LASA drugs, and conducting supplier performance evaluation. ","PeriodicalId":517328,"journal":{"name":"Jurnal Teknologi dan Manajemen","volume":"125 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Supply Chain Risk Management Assessment and Strategy: Case Study in a Hospital Pharmacy\",\"authors\":\"Mushonnifun Faiz Sugihartanto, Muhammad Rizaldy Mahendra, Imam Baihaqi, Hanifa Rizaldy\",\"doi\":\"10.52330/jtm.v22i1.230\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Health service providers such as hospitals have a very diverse supply chain in quantity and type, one of which is medicine. Hospital Pharmacy Installation (IFRS) is one of the health support activity units responsible for planning, procurement, management, storage, distribution, use of drugs, equipment, and pharmaceutical services for medical devices related to the distribution of drugs used in hospitals. Pharmacy has several risks that need to be addressed to increase customer satisfaction. This study aims to determine the extent of the implementation of Supply Chain Risk Management, identify risks in supply chain activities, and obtain risk management strategies. In this study, the method used is the assessment of Supply Chain Risk Management and continued the evaluation of the drug chain in pharmaceutical installations with the House of Risk. It is divided into two stages, namely House of Risk Stage 1, which is used to decide the risk in each supply chain, and House of Risk Stage 2, to offers a decision-making strategy for each chosen decision. There are 20 risk events and 20 risk agents in the House of Risk stage 1, and 11 proposed risk management strategies in the House of Risk stage 2. Out of 20 risks identified in stage 1, 11 risks contributed to 80% highest risk, and the top three are drug shortage, inappropriate planning, and unclear doctor’s writing. In stage 2, the three most prioritized strategies are e-prescription implementation, clear signs for LASA drugs, and conducting supplier performance evaluation. \",\"PeriodicalId\":517328,\"journal\":{\"name\":\"Jurnal Teknologi dan Manajemen\",\"volume\":\"125 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Jurnal Teknologi dan Manajemen\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52330/jtm.v22i1.230\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurnal Teknologi dan Manajemen","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52330/jtm.v22i1.230","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

医院等医疗服务提供者的供应链在数量和类型上都非常多样化,药品就是其中之一。医院药房装置(IFRS)是卫生支持活动单位之一,负责规划、采购、管理、储存、分发、使用药品、设备和与医院药品分发有关的医疗器械的制药服务。药房有几个风险需要解决,以提高客户满意度。本研究旨在确定供应链风险管理的实施程度,识别供应链活动中的风险,并获得风险管理策略。在本研究中,使用的方法是评估供应链风险管理,并继续对制药厂的药品链与风险之家进行评估。它分为两个阶段,即风险之家第一阶段,用于决定每个供应链的风险;风险之家第二阶段,为每个选定的决策提供决策策略。风险之家 "第 1 阶段有 20 个风险事件和 20 个风险代理,"风险之家 "第 2 阶段有 11 个拟议的风险管理策略。在第 1 阶段确定的 20 个风险中,有 11 个风险造成了 80% 的最高风险,排在前三位的是药品短缺、计划不当和医生书写不清。在第 2 阶段,最优先考虑的三个策略是实施电子处方、为 LASA 药品设置清晰标志和进行供应商绩效评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Supply Chain Risk Management Assessment and Strategy: Case Study in a Hospital Pharmacy
Health service providers such as hospitals have a very diverse supply chain in quantity and type, one of which is medicine. Hospital Pharmacy Installation (IFRS) is one of the health support activity units responsible for planning, procurement, management, storage, distribution, use of drugs, equipment, and pharmaceutical services for medical devices related to the distribution of drugs used in hospitals. Pharmacy has several risks that need to be addressed to increase customer satisfaction. This study aims to determine the extent of the implementation of Supply Chain Risk Management, identify risks in supply chain activities, and obtain risk management strategies. In this study, the method used is the assessment of Supply Chain Risk Management and continued the evaluation of the drug chain in pharmaceutical installations with the House of Risk. It is divided into two stages, namely House of Risk Stage 1, which is used to decide the risk in each supply chain, and House of Risk Stage 2, to offers a decision-making strategy for each chosen decision. There are 20 risk events and 20 risk agents in the House of Risk stage 1, and 11 proposed risk management strategies in the House of Risk stage 2. Out of 20 risks identified in stage 1, 11 risks contributed to 80% highest risk, and the top three are drug shortage, inappropriate planning, and unclear doctor’s writing. In stage 2, the three most prioritized strategies are e-prescription implementation, clear signs for LASA drugs, and conducting supplier performance evaluation. 
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信